Plecanatide & Linaclotide are two drugs made by two different companies but both target Irritable Bowel Syndrome in a similar way.

Plecanatide is being developed by Synergy Pharmaceuticals while Linaclotide is being developed by Ironwood Pharmaceuticals. These drugs are targeted towards those with constipation predominant IBS with associated IBS related abdominal pain. Continue reading “Plecanatide & Linaclotide, Similar Experimental Treatments For IBS” »

Research led by Fang Yang at the Vanderbilt University Medical Center has uncovered some interesting information which could lead to new treatments for Inflammatory Bowel Diseases like Crohn’s Disease or Ulcerative Colitis.

The researchers focused in on proteins that are secreted by the Lactobacillus rhamnosus GG bacteria. This bacteria is commonly found in yogurts. The proteins they isolated were given generic names such as p75 & p40. Researchers narrowed their focus to protein ‘p40’. P40 was found to activate the epidermal growth factor receptor which is responsible for sustaining living cells & growing new ones. Activation of this receptor appears to have helped prevent both cell death & inflammation caused by weakening of the intestinal tracts “tight junctions” which prevent microbes & toxins escaping into the bloodstream. Continue reading “Yogurt Protein Could Be Helpful For Inflammatory Bowel Diseases” »

Canadian Researchers from the University of Toronto have narrowed down a key protein which may be partially to blame for triggering Crohn’s Disease.

The proteins in question are known as “nucleotide-binding oligomerization domain proteins” or NOD for short. The study looked specifically at the NOD2 gene which acts as a sort of “bacterial sensor” for the gut. It helps the immune system respond to threats by sending out signaling molecules(cytokines) which trigger an inflammatory response. The cytokines  seen in this study are Interleukin(IL) 17 & IL-22. Interleukin 23 has also been linked to Crohn’s Disease. The research suggests that the NOD2 gene miscommunicates with IL-17 & IL-22 impeding the bodies ability to fight off bacterial infection. Continue reading “Immune System Proteins Key In Crohn’s Disease” »

Canadian researchers from the University of Toronto released info on a study that looks at the impact physical abuse as a child plays in developing chronic illnesses like Chronic Fatigue Syndrome, Irritable Bowel Syndrome or Fibromyalgia.

“Women who reported they had been physically abused as children have twice the odds of chronic fatigue syndrome and multiple chemical sensitivities, and 65 per cent higher odds of fibromyalgia” says lead investigator Professor Esme Fuller-Thomson Continue reading “Abusive Childhood Could Play Part In IBS, Chronic Fatigue & Fibromyalgia” »

Athletes, who are usually thought to be the epitome of health, often deal with the devastating impacts of digestive illness.

While our favorite sports heroes may seem superhuman many of them must face diseases like Diabetes, Cancer, Irritable Bowel Syndrome,  Inflammatory Bowel Diseases & other ailments just like everyone else.  While it can be embarrassing to talk about digestive diseases, many athletes do step forward & share their story, helping to gain awareness & understanding. Continue reading “Major League & College Baseball Players Deal With IBS & IBD” »

Asimadoline may see use in treating Irritable Bowel Syndrome sooner thanks to being “fast tracked” by the FDA.

Tioga Pharmaceuticals announced via press release that they have received fast track status from the FDA on their drug Asimadoline. Asamadoline is an agonist which binds to the kappa opioid receptor. The kappa opioid receptors reside in the brain, spinal cord & peripheral nervous system. Asimadoline is targeted to work on the peripheral nervous system, while avoiding the brain due to it’s inability to cross past the blood brain barrier. Clinical trials of Asimadoline show that the drug is helpful with treating pain, discomfort & urgency in those with diarrhea predominant IBS symptoms. Continue reading “Asimadoline IBS Drug Gets Fast Tracked By FDA” »

Copyright © 2024 The Digestion Blog - Mark & Gabriel Hedges.

Privacy Policy